Leading cleaning and sanitation products maker
) recently inaugurated a new training facility in Eagan,
Minnesota. The 51,000-square-feet center will be primarily used
to train field associates from the company's Institutional
Division. In addition, the company has kept sufficient provisions
to expand its Research, Development and Engineering (RD&E)
work at the center.
Ecolab's Institutional business under the U.S. Cleaning and
Sanitizing segment manufactures specialized cleaners and
sanitizers as well as food safety and hospitality products to
cater to a wide range of customers such as hotels, restaurants,
commercial buildings, healthcare and military facilities.
The Institutional Division markets its offerings mainly via
company-employed field sales personnel. Management built the
Institutional Training Center to educate these salesmen regarding
its specialized products and programs, in an effort to provide
better customer support.
Ecolab plans to train more than 2,000 sales executives and
conduct 130 sessions at this facility in the next few years.
Moreover, the additional space for RD&E will be used to
develop new products for the Institutional business as well as
other cleaning and sanitizing franchises under the company.
One of Ecolab's peers,
), a leading healthcare products maker, has already set up The
Covidien Clinical Institute ("CCI") in China. This facility
imparts training to local healthcare professionals regarding
proper and effective use of latest offerings.
St. Paul, Minnesota-based Ecolab serves the food service, food
and beverage processing, healthcare, energy, water treatment and
hospitality markets both in the U.S. as well as internationally.
The company continues to invest in strategic areas such as health
care, food, water and energy, and global pest elimination to
expand its business.
We currently have a 'Neutral' recommendation on Ecolab. The stock
carries a short-term Zacks #3 Rank (Hold rating).
COVIDIEN PLC (COV): Free Stock Analysis
ECOLAB INC (ECL): Free Stock Analysis Report
To read this article on Zacks.com click here.